fb-pixel tracker
News

Caris Life Sciences Launches MI FOLFOXai, Improving Overall Survival by 50% for Metastatic Colorectal Cancer Patients

First AI-powered FOLFOX predictor to guide first-line metastatic colorectal cancer treatment   IRVING, Texas, March 31, 2020 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced the launch of MI FOLFOXai, the newest addition to the company’s suite of comprehensive molecular science offerings. MI … Continued

Study Shows That Caris Life Sciences’ ADAPT Biotargeting System™ Has Discovered Protein Expression Pattern Differences Between Two Prostate Cancer Patient Subpopulations

First time findings published in Nucleic Acids Research demonstrate the ability to differentiate exosomes from cancer cell subtypes from the same tumor type offering broad potential applications in biomarker discovery   IRVING, Texas, Feb. 12, 2020 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today … Continued

Caris Life Sciences Appoints New Executive Medical Director

IRVING, Texas, Feb. 11, 2020 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today Matthew Oberley, M.D., Ph.D., has been appointed Executive Medical Director.   Dr. Oberley joined Caris in August 2019 as Senior Medical Director and has functioned as a leading face for … Continued

Cedars-Sinai Joins Caris Life Sciences’ Precision Oncology Alliance

Nationally recognized center becomes 33rd member of Caris’ collaborative network focused on expanding the application of precision medicine in cancer treatment   IRVING, Texas & LOS ANGELES, Calif., Jan. 14, 2020 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that the Samuel Oschin … Continued

Caris Life Sciences to Present Data Evaluating PI3K Pathway Alterations at the 2019 San Antonio Breast Cancer Symposium (SABCS)

IRVING, Texas, December 10, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that it will present results from a study evaluating the prevalence of phosphatidylinositol-3-kinase (PI3K)/AKT/PTEN pathway alterations and co-alterations in patients with different subtypes of breast cancer. The molecular profiles of … Continued

Caris Life Sciences and Ambry Genetics Partner to Advance Cancer Care

Partnership combines Caris’ somatic and Ambry’s germline testing strengths to provide clinicians with unique information about the molecular and genetic components of a patient’s cancer   IRVING, Texas and ALISO VIEJO, Calif., December 4, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, and Ambry Genetics … Continued

1 2 3 22

About Our News

Search to find the latest new about Caris Molecular Intelligence®, sign up for news alerts, and be sure to follow us on social media.